Search Press releases Keywords From To 8 Jan 2022 Disposals of own shares Read More 3 Jan 2022 Disposals of own shares Read More 21 Dec 2021 Disposals of own shares Read More 16 Dec 2021 Positive Top-Line Results for BIMZELX[®]▼(bimekizumab) in Phase 3 Ankylosing Spondylitis Trial Read More 10 Dec 2021 UCB announces positive Phase 3 results for rozanolixizumab in generalized myasthenia gravis Read More 3 Dec 2021 Disposals of own shares Read More Pagination First page Previous page Previous … Page 50 Page 51 Page 52 Page 53 Current page 54 Page 55 Page 56 Page 57 Page 58 … Page 54 of 67 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
